Diana is a medical doctor with a specialty in Neurorehabilitation. She received her medical degree from University of Aguascalientes, Mexico in 2002, Fellowship in Neurological Rehabilitation from IAHP, Philadelphia, USA in 2006; M.Sc in Neurological Rehabilitation in 2009, Fellowship in Neurophysiology from University Hospital, Cleveland, USA in 2012 and Ph.D. from De Montfort University from Leicester, UK in 2018. She has 15 years of experience treating severe brain injured patients in United States, Mexico, Spain, Italy, China, Brazil, Colombia and Honduras. She developed, along with other professionals, an integrative intervention to rehabilitate neurological conditions including neurofeedback and other non-invasive brain stimulation techniques. She is the CEO (since 2012) of Neocemod (Neuromodulation Center), Mexico City and Aguascalientes, Mexico, with experience treating patients with epilepsy, learning disorders, behavioral disorder, mood disorders, sleep disorders, TBI and CP. She has extensive experience in neurophysiology and EEG/qEEG/ERP interpretation. Also, she is an international consultant for neurofeedback professionals and currently she combines clinical work, and research; which lead to study the effects of neurofeedback in epilepsy for her Ph.D. thesis. She continues to received invitations to give lectures and workshops for ISNR, BFE, NRBS and SMNB (Mexican Neurofeedback society) and other international neurological and neurophysiology societies.

In 2017 she became the Director of Neurofeedback Clinic at Trauma Center at JRI in Boston and currently she is cofounder of Boston Neurodynamics offering high quality training and consulting for neurophysiological evaluations, neurofeedback, biofeedback and noninvasive brain stimulation interventions

Angelika is a psychologist that has been in private practice since 1987. Once introduced to neurofeedback, she found the knowledge of the brain provided a tool to help patients change in a way that had often taken years with psychotherapy alone. As she incorporated neurofeedback into my practice, the desire to learn about this method was insatiable and took her to Switzerland, where she learned of the HBI database. With the research behind this method and the introduction of event related potentials as a means of understanding brains, it seemed that neurofeedback and then biofeedback, were to become integral tools in my work. Since 2006, She has treated thousands of patients and have presented at numerous events to train other clinicians in this method. She has been grateful to learn from leaders in the field including Jay Gunkelman, who has kindly devoted hundreds of hours to teach me.

It has been her pleasure to be the executive director of the Northeast Region Biofeedback Society for the past 5 years and to consult with numerous clinicians who embarked on developing their assessment and neurofeedback skills. Presently, she is interested in utilizing the latest research to make objective assessments to help people improve their lives. In partnering with HBI, she is eager to help other clinicians have access to assessments that are based on quantitative comparisons of measurements of the EEG and ERPs.

Member: International Society for Neurofeedback and Research Pennsylvania Psychological Association Northeast Region Biofeedback Society EEG Education and Research Board Certified in Neurofeedback and Heart Rate Variability: Biofeedback Certification International Alliance

Mitchell is a clinical psychologist who has been practicing neurofeedback since the late nineties. As he integrated neurofeedback into his practice he became aware of the utility of an objective brainwave assessment in addition to a thorough clinical history. At that time, the cost of a qEEG was prohibitive to most of the people seeking help at our clinic, so he developed a version of the Mini-Q based on the work of Paul Swingle, Ph.D. This was used as a part of our evaluation process for several years. Once the cost of qEEGs became more affordable, their use became routine in our clinic and have been used to develop hundreds of protocols for patients of all ages with various presenting complaints ranging from ADHD to autism, anxiety/depression, migraines, TBI, peak performance, etc. Several years ago I was introduced to the value of assessing event related potentials (ERPs) through Andreas Muller, Ph.D., and Yuri Kropotov and added this measure to our clinical evaluation process.

He has sought ongoing training from these individuals as well as Jay Gunkleman, and see ERPs as a key component in the future of our field and acceptance of our field by the medical community. As President of the Board of the Northeast Region Biofeedback Society for the past 4 years he has had the opportunity to interact with a wide range of practitioners. I have learned from them and become aware of what might help them to increase the treatment successes they are already having.

His interest is in disseminating the benefits of qEEG, ERPs, neurofeedback and biofeedback to mental health and health providers, having such people have access to understandable and practical assessment results and recommendations.

Member: American Psychological Association, Pennsylvania Psychological Association, Northeast Region Biofeedback Society, EEG Info Board Certified in Neurofeedback and Heart Rate Variability: Biofeedback Certification International Alliance

Andreas is an expert in the study of the human brain. For the past 17 years he has been the CEO of the Bündner Brain and Trauma Foundation has been exploring the links between biology and mental disorders – for example in ADHD. Previously the head of the School Psychology Service Graubünden together with the world-famous Russian neurophysiologist Yuri Kropotov, in 2003 he initiated his first research project: recordings of brainwaves of 250 healthy children and adolescents to create a database. As early as 2004, the database was expanded by 540 adults. Together with people from Norway and Russia, the people of Grisons formed the basis of an index database on the human brain. Müller has been CEO of the Brain and Trauma Foundation in Grisons since 2006.

Comparatively new to Müller’s research is that mental illness can be objectively detected by quantitative comparisons of measurements with the so-called EEG. Müller likes to make use of a comparison from another area of ​​medicine: “Psychiatry is today at the point where surgery in the invention of the X-ray apparatus was more than 100 years ago.” Muller and his colleagues have studied the biological causes of Attention-Deficit / Hyperactivity Disorder (ADHD) with particular interest. According to Müller, this research focus has come from everyday practice as a child and adolescent psychologist. “Our research must benefit patients exclusively.” ADHD visible in black on white, Muller has since lectured internationally on this topic in South Korea, United States, Israel, Brazil and more. For the method, among other things, the patients have to analyze images on the PC for 22 minutes and click on the correct sequence with a computer mouse. “Persons affected by ADHD are very hard-eyed anyway,” says Müller. Because the brain waves were measured during the test, the researchers could also objectively detect the disorder – black and white. The method enables a virtually unequivocal diagnosis of ADHD, says Müller. “Thanks to the measurements, we also know what we need to do in therapy.” In addition to detailed instructions for the procedure in non-drug therapies, he mentions the great advantages of prescribing drugs such as Ritalin. “In conventional diagnoses, around two-thirds of patients respond to the medication. The method provides virtually 100% responder quality. This same method has been expanded to understanding chronic pain, anxiety, Parkinson’s disease, and more.

Prof. Juri Kropotov is a leading expert in the basic and applied neuroscience. The unique methodology developed in his labs at the Human Brain Institute in St Petersburg (Russia) allows a sophisticated analysis of brain electric activity in resting states and under task conditions. The methodology is described in his book Kropotov, J.D. (2009). Quantitative EEG, event-related potentials and neurotherapy. London: Academic Press. These precise measurements of brain function can be used as Neuromarkers in the clinical context to evaluate brain health in different psychiatric and neurological disorders. The experience of translating this methodology into clinical practice is presented in his recently published book Kropotov, J. D. (2016). Functional neuromarkers for psychiatry: Applications for diagnosis and treatment. San Diego, CA, US: Elsevier Academic Press. 

His scientific and research career spans 45 years of dedicated work in Brain science. Juri Kropotov, PhD. has earned three doctorates: in theoretical physics, in philosophy and  neurophysiology. From 1970 to 1990, he practiced at the psychiatric clinics of the Institute of Experimental Medicine and Institute of the Human Brain at the Russian Academy of Sciences in St. Petersburg. 

His work with psychiatric patients included electrode implantation for neurological research, evaluation, diagnosis and therapy. For this research, in 1985 he was awarded the country’s highest scientific award – the USSR State Prize. 

His scientific interests are now focused on quantitative EEG and normative data bases, event-related potentials (ERPs), Neurotherapy (Neurofeedback, tDCS, DBS), QEEG/ERP markers of psychiatric and neurological disorders. His achievements include many years 

Find some of the books from Dr. Juri Kropotov @ Amazon